The Safety and Efficacy of Standard-Dose versus Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Left Atrial Appendage Thrombus

Table 2

LAAT resolution by different doses of NOACs.

	Standard-dose group (n = 14)			Low-dose group (n = 10)
	Resolved	Reduced	Unchanged	Resolved	Reduced	Unchanged
1 month	4	8	2	3	5	2
2 months	4	4	2	3	3	1
3 months	4	1	1	2	0	2
Total, n (%)	12 (85.7)	1 (7.1)	1 (7.1)	8 (80)	1 (10)	1 (10)